Clinical Trials Logo

Clinical Trial Summary

This is a study to investigate the functional consequences of paraprotein production in MGUS (Monoclonal Gammopathy of Unknown Significance).


Clinical Trial Description

Monoclonal gammopathy of unknown significance (MGUS) is a common haematological condition. It is characterised by proliferation of a B lymphocyte clone and it's associated antibody (paraprotein). In most cases there are no clinical symptoms, however, in a small number of individuals there may be an interaction of the paraprotein with a molecule expressed by the body (self antigen). This can have effects on the normal function of this molecule and/or cause disease.

The study aims to investigate the functional consequences of paraprotein production in MGUS. ;


Study Design


Related Conditions & MeSH terms

  • Monoclonal Gammopathy of Undetermined Significance
  • Monoclonal Gammopathy of Unknown Significance
  • Paraproteinemias

NCT number NCT02933021
Study type Observational
Source Human Antibody Factory Limited
Contact
Status Active, not recruiting
Phase
Start date July 2016
Completion date February 28, 2021